Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1590/S1806-37132014000200003 http://repositorio.unifesp.br/handle/11600/44158 |
Resumo: | Objective: To investigate the modulatory effects that dynamic hyperinflation (UFO, defined as a reduction in inspiratory capacity (lC), has on exercise tolerance after bronchodilator in patients with COPD. Methods: An experimental, randomized study involving 30 COPD patients without severe hypoxemia. At baseline, the patients underwent clinical assessment, spirometry, and incremental cardiopulmonary exercise testing (CPET). On two subsequent visits, the patients were randomized to receive a combination of inhaled fenoterol/ipratropium or placebo. All patients then underwent spirometiy and submaximal CPET at constant speed up to the limit of tolerance (Tlim). The patients who showed Delta lC(peak-rest) < 0 were considered to present with DH (DH+). Results: In this sample, 21 patients (70%) had DH. The DH+ patients had higher airflow obstruction and lower Tlim than did the patients without Did (DH-). Despite equivalent improvement in FEV1 after bronchodilator, the DH- group showed higher Delta lC(bronchodilator-placebo) at rest in relation to the DH+ group (p < 0.05). However, this was not found in relation to Delta lC at peak exercise between DH+ and DH- groups (0.19 +/- 0.17 L vs. 0.17 +/- 0.15 L, p > 0.05). in addition, both groups showed similar improvements in Tlim after bronchodilator (median [interquartile range]: 22% [3-60% vs. 10% [3-53%]; p > 0.05). Conclusions: Improvement in TLim was associated with an increase in lC at rest after bronchodilator in HD- patients with COPD. However, even without that improvement, COPD patients can present with greater exercise tolerance after bronchodilator provided that they develop DH during exercise. |
id |
UFSP_7e83025b5b9f71417c71ea57634b339c |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/44158 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation?Pulmonary diseasechronic obstructiveBronchodilator agentsExercise testExercise toleranceInspiratory capacityObjective: To investigate the modulatory effects that dynamic hyperinflation (UFO, defined as a reduction in inspiratory capacity (lC), has on exercise tolerance after bronchodilator in patients with COPD. Methods: An experimental, randomized study involving 30 COPD patients without severe hypoxemia. At baseline, the patients underwent clinical assessment, spirometry, and incremental cardiopulmonary exercise testing (CPET). On two subsequent visits, the patients were randomized to receive a combination of inhaled fenoterol/ipratropium or placebo. All patients then underwent spirometiy and submaximal CPET at constant speed up to the limit of tolerance (Tlim). The patients who showed Delta lC(peak-rest) < 0 were considered to present with DH (DH+). Results: In this sample, 21 patients (70%) had DH. The DH+ patients had higher airflow obstruction and lower Tlim than did the patients without Did (DH-). Despite equivalent improvement in FEV1 after bronchodilator, the DH- group showed higher Delta lC(bronchodilator-placebo) at rest in relation to the DH+ group (p < 0.05). However, this was not found in relation to Delta lC at peak exercise between DH+ and DH- groups (0.19 +/- 0.17 L vs. 0.17 +/- 0.15 L, p > 0.05). in addition, both groups showed similar improvements in Tlim after bronchodilator (median [interquartile range]: 22% [3-60% vs. 10% [3-53%]; p > 0.05). Conclusions: Improvement in TLim was associated with an increase in lC at rest after bronchodilator in HD- patients with COPD. However, even without that improvement, COPD patients can present with greater exercise tolerance after bronchodilator provided that they develop DH during exercise.Fac Ciencias Med Paraiba, Joao Pessoa, Paraiba, BrazilUniv Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, BrazilFac Med ABC, Disciplina Pneumol, Santo Andre, SP, BrazilFac Med ABC, Disciplina Pneumol, Setor Reabilitacao Pulmonar, Santo Andre, SP, BrazilQueens Univ, Div Resp & Crit Care Med, Kingston, ON, CanadaKingston Gen Hosp, Kingston, ON, CanadaUniv Fed Sao Paulo, Sao Paulo, BrazilUniv Fed Sao Paulo, Sao Paulo, BrazilWeb of ScienceSoc Brasileira Pneumologia TisiologiaFac Ciencias Med ParaibaUniv Fed Rio Grande do SulFac Med ABCQueens UnivKingston Gen HospUniversidade Federal de São Paulo (UNIFESP)Scuarcialupi, Maria Enedina AquinoBerton, Danilo CortoziCordoni, Priscila KessarSquassoni, Selma DenisFiss, ElieNeder, Jose Alberto [UNIFESP]2018-06-15T17:49:55Z2018-06-15T17:49:55Z2014-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion111-118http://dx.doi.org/10.1590/S1806-37132014000200003Jornal Brasileiro De Pneumologia. Brasilia Df: Soc Brasileira Pneumologia Tisiologia, v. 40, n. 2, p. 111-118, 2014.10.1590/S1806-37132014000200003S1806-37132014000200111-en.pdfS1806-37132014000200111-pt.pdf1806-3713S1806-37132014000200111http://repositorio.unifesp.br/handle/11600/44158WOS:000334569100003porJornal Brasileiro De Pneumologiainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-05-02T15:58:50Zoai:repositorio.unifesp.br/:11600/44158Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-05-02T15:58:50Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation? |
title |
Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation? |
spellingShingle |
Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation? Scuarcialupi, Maria Enedina Aquino Pulmonary disease chronic obstructive Bronchodilator agents Exercise test Exercise tolerance Inspiratory capacity |
title_short |
Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation? |
title_full |
Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation? |
title_fullStr |
Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation? |
title_full_unstemmed |
Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation? |
title_sort |
Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation? |
author |
Scuarcialupi, Maria Enedina Aquino |
author_facet |
Scuarcialupi, Maria Enedina Aquino Berton, Danilo Cortozi Cordoni, Priscila Kessar Squassoni, Selma Denis Fiss, Elie Neder, Jose Alberto [UNIFESP] |
author_role |
author |
author2 |
Berton, Danilo Cortozi Cordoni, Priscila Kessar Squassoni, Selma Denis Fiss, Elie Neder, Jose Alberto [UNIFESP] |
author2_role |
author author author author author |
dc.contributor.none.fl_str_mv |
Fac Ciencias Med Paraiba Univ Fed Rio Grande do Sul Fac Med ABC Queens Univ Kingston Gen Hosp Universidade Federal de São Paulo (UNIFESP) |
dc.contributor.author.fl_str_mv |
Scuarcialupi, Maria Enedina Aquino Berton, Danilo Cortozi Cordoni, Priscila Kessar Squassoni, Selma Denis Fiss, Elie Neder, Jose Alberto [UNIFESP] |
dc.subject.por.fl_str_mv |
Pulmonary disease chronic obstructive Bronchodilator agents Exercise test Exercise tolerance Inspiratory capacity |
topic |
Pulmonary disease chronic obstructive Bronchodilator agents Exercise test Exercise tolerance Inspiratory capacity |
description |
Objective: To investigate the modulatory effects that dynamic hyperinflation (UFO, defined as a reduction in inspiratory capacity (lC), has on exercise tolerance after bronchodilator in patients with COPD. Methods: An experimental, randomized study involving 30 COPD patients without severe hypoxemia. At baseline, the patients underwent clinical assessment, spirometry, and incremental cardiopulmonary exercise testing (CPET). On two subsequent visits, the patients were randomized to receive a combination of inhaled fenoterol/ipratropium or placebo. All patients then underwent spirometiy and submaximal CPET at constant speed up to the limit of tolerance (Tlim). The patients who showed Delta lC(peak-rest) < 0 were considered to present with DH (DH+). Results: In this sample, 21 patients (70%) had DH. The DH+ patients had higher airflow obstruction and lower Tlim than did the patients without Did (DH-). Despite equivalent improvement in FEV1 after bronchodilator, the DH- group showed higher Delta lC(bronchodilator-placebo) at rest in relation to the DH+ group (p < 0.05). However, this was not found in relation to Delta lC at peak exercise between DH+ and DH- groups (0.19 +/- 0.17 L vs. 0.17 +/- 0.15 L, p > 0.05). in addition, both groups showed similar improvements in Tlim after bronchodilator (median [interquartile range]: 22% [3-60% vs. 10% [3-53%]; p > 0.05). Conclusions: Improvement in TLim was associated with an increase in lC at rest after bronchodilator in HD- patients with COPD. However, even without that improvement, COPD patients can present with greater exercise tolerance after bronchodilator provided that they develop DH during exercise. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-03-01 2018-06-15T17:49:55Z 2018-06-15T17:49:55Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/S1806-37132014000200003 Jornal Brasileiro De Pneumologia. Brasilia Df: Soc Brasileira Pneumologia Tisiologia, v. 40, n. 2, p. 111-118, 2014. 10.1590/S1806-37132014000200003 S1806-37132014000200111-en.pdf S1806-37132014000200111-pt.pdf 1806-3713 S1806-37132014000200111 http://repositorio.unifesp.br/handle/11600/44158 WOS:000334569100003 |
url |
http://dx.doi.org/10.1590/S1806-37132014000200003 http://repositorio.unifesp.br/handle/11600/44158 |
identifier_str_mv |
Jornal Brasileiro De Pneumologia. Brasilia Df: Soc Brasileira Pneumologia Tisiologia, v. 40, n. 2, p. 111-118, 2014. 10.1590/S1806-37132014000200003 S1806-37132014000200111-en.pdf S1806-37132014000200111-pt.pdf 1806-3713 S1806-37132014000200111 WOS:000334569100003 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
Jornal Brasileiro De Pneumologia |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
111-118 |
dc.publisher.none.fl_str_mv |
Soc Brasileira Pneumologia Tisiologia |
publisher.none.fl_str_mv |
Soc Brasileira Pneumologia Tisiologia |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268403058212864 |